(Q65388637)
Statements
Presentation of Renal Function in Liver Transplant Recipients With Certican Therapy: PROTECT Study A Twelve-month, Multicenter, Randomized, Open-label Study of Safety, Tolerability and Efficacy of Certican-based Regimen Versus Calcineurin Inhibitor-based Regimen in de Novo Liver Transplant Recipients (English)
0 references
August 2006
0 references
January 2013
0 references
276
0 references
18 year
0 references
70 year
0 references